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Helicobacter pylori (H. pylori) is considered the secondmost prevalent infection inman. A precise diagnosis is important for treating
patients with the indicative gastrointestinal symptoms.e present study analyzes the effectiveness of a molecular biology method
(PCR) comparing the results obtained with the histology and with the rapid urease tests. PCR was used in the detection and
genotyping of theH. pylori urease-C gene and the patterns which were obtained from the patients studied. 141 biopsy samples from
131 patients were evaluated. 59 paraffin biopsies samples were positive for H. pylori according to the histological examination. Of
those, 59/12 (20.3%) were ampli�ed using PCR.Of the 82 samples from the fresh biopsies, 64were positive forH. pylori according to
the rapid urease test (78%); there was an agreement of 100%with PCR. Sixty positiveH. pylori samples were genotyped (58 samples
of fresh biopsies and 2 samples of paraffin biopsies) using two restriction enzymes. e patterns observed were analyzed with the
computational program BIO 1D; 11 patterns with the enzymeHhaI and 12 patterns with the enzymeMboI were found. However, it
was not possible to �nd a statistically signi�cant correlation between the speci�c genotypes and digestive pathologies. Accordingly,
future research should be performed to con�rm a statistically signi�cant relationship between genotyping and gastrointestinal
symptoms.
1. Introduction
e Helicobacter pylori (H. pylori) infection is currently
endemic worldwide with high prevalence (up to 60%) in
developing regions such as South America. e infection
causes chronic Gastritis, gastric and duodenal ulcers, gastric
adenocarcinoma, and mucosa-associated lymphoid tissue
[1–6]. H. pylori is associated with several autoimmune dis-
eases, including idiopathic thrombocytopenic purpura (ITP),
Sjögren syndrome, systemic sclerosis [7], Graves’ disease
[8], and autoimmune pancreatitis [9]. As a result of this
association with autoimmune diseases, we hypothesized that
H. pylori might induce systemic immunological changes.
Although the seroprevalence of H. pylori may be high in the
normal population, a minority develops peptic ulcers [10,
11]. Some possibilities could justify this data: genetic differ-
ences in the host’s environmental factors and bacterial strains.
A variety of tests are now available to diagnose H. pylori
infection. Histological examination of gastric tissue, bacterial
cultures, rapid urease test, use of DNA probes, and PCR anal-
ysis, when used to test gastric tissue, all require endoscopy. In
contrast, breath tests, serology, gastric juice PCR, and urinary
excretion of N15 ammonia are noninvasive tests that do not
require endoscopy. PCR offers high sensitivity and speci�city
as a technique for the detection of H. pylori although the
accuracy of such techniques varieswidely [12].e aimof this
work is to analyze the effectiveness of the molecular biology
method PCR in the detection of H. pylori in patients with
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T 1: Patient characteristics.
Total (𝑛𝑛 𝑛 𝑛𝑛𝑛)
Patients
Sex (male/female) 81/50
Age years (median) 48 years (range 4–90)
Disease
Gastritis 99 (70.2%)
Ulcers 29 (20.6%)
Gastritis + ulcers 5 (3.5%)
Esophagitis 3 (2%)
Other∗ 5 (3.5%)
∗
In�ammation, duodenitis, and splenomegaly.
gastrointestinal symptoms, comparing the results with the
histology and the rapid urease test and using the PCR-RFLP
technique to detect H. pylori subtypes in endoscopic biopsy
samples obtained from Brazilian patients.
2. Material andMethods
2.1. Patients. 141 samples were collected from 131 patients
with several diagnoses of gastrointestinal pathologies.
Among them, 99 patients who were involved in this study
had Gastritis, 29 had ulcers, 5 had Gastritis and ulcers, 3 had
esophagitis, and 5 had other gastrointestinal diseases. e
patients were 48 years old on average; their ages varied from
4 to 90 years old. 81 were males and 50 females (Table 1). All
patients were submitted to an endoscopy at the Gastrocentro
(Center of Digestive Tract Studies), University Hospital, State
University of Campinas, SP, Brazil, aer informed consent
was obtained and protocol approved by the Hospital’s Ethics
Committee.
2.2. Methods. e methods used for the detection of H.
pyloriwere polymerase chain reaction (PCR) and PCR-RFLP
for genotyping. ey were chosen in order to detect the
bacterium and its subtypes in endoscopic biopsies of fresh
tissues and paraffin tissues. e fresh biopsy samples were
conserved in physiologic serum 0.9% until the DNA was
extracted. At least two, 5 to 10mm, ribbons of paraffin were
collected from the paraffin tissue. In the fresh biopsies, at least
two fragments were collected.
2.2.1. DNA Extraction—Gastric Paraffin Biopsy. DNA ext-
raction from the endoscopic biopsies fastened in paraffin
followed themethod described byDavis et al., 1995 [13], with
some modi�cations.
At least two, 5 to 10mm, ribbons of paraffin were placed
in a 1.5 mL Eppendorf tube. One mL of xylene was added
to the samples. ey were shaken, allowed to rest for 3 to
5 minutes, and then centrifuged for 5 minutes, discarding
the xylene aerwards. Aer three washes in 100%, 95%,
and 70% ethanol, respectively, the samples were dried at
room temperature. Next, the material was resuspended in
a solution of Proteinase K, 50mM Tris, 0.5% SDS, and
sterile water. 430 𝜇𝜇L of phenol were added to the sample,
which was homogenized and centrifuged for another 30min-
utes at 14,000 RPM. e supernatant containing DNA was
transferred to a new tube and 430 𝜇𝜇L of phenol/chloroform
(1 : 1) were added and centrifuged again for 5 minutes at
14,000 RPM. Chloroform/isoamyl ethanol was added (24 : 1)
to the supernatant, which was homogenized and centrifuged
for another 30 minutes at 14,000 RPM. Aer the addition
of 75 𝜇𝜇L of ammonium acetate and 750 𝜇𝜇L of 100%, ethanol
samples were inverted several times and incubated overnight
to −20∘C. Aer centrifugation for 30 minutes at 12,000 RPM
to −4∘C, the supernatant was discarded. e precipitate was
carefully washed with 500 𝜇𝜇L of chilled 70% ethanol, which
was immediately discarded. e material was dried at room
temperature and resuspended in a solution containing 50mL
of sterile water, 10M of Tris (pH 8.0), and 1mL of EDTA and
stored at −20∘C until its use.
2.2.2. DNA Extraction: Fresh Biopsy. Firstly, a fresh 3 to
7mm biopsy section was placed in a 1.5mL sterile tube with
190 𝜇𝜇L of a solution that contained 0.1M of Tris HCl (pH
7.5) and 1% of SDS. Secondly, 10 𝜇𝜇L of proteinase K were
added (10mg/mL) to the solution.e sample wasmacerated
and incubated overnight at 55∘C. Aer that, 200 𝜇𝜇L of
phenol and 200 𝜇𝜇L of both chloroform and isoamyl alcohol
(24 : 1) were added. e solution was then homogenized
and centrifuged for one minute. Next, the supernatant was
removed, and 200 𝜇𝜇L of chloroform/isoamyl alcohol were
added, homogenized, and centrifuged for 1 minute. Next,
the supernatant was removed again, and 25𝜇𝜇L of sodium
acetate 3M and 900𝜇𝜇L of 100% ethanol at −20∘Cwere added;
aer vortexing the mixture, it was incubated for 30 minutes
at −70∘C. e samples were centrifuged for 15 minutes at
15,000 RPM.e supernatant was discarded. Lastly, the DNA
was resuspended in 25 𝜇𝜇L of distilled and sterile water. [14].
2.2.�. P�� A�pli�cation o� the H. pylori. e polymerase
chain reaction followed the method described by Saiki and
col. [15], with some modi�cations.
For each ampli�cation reaction, 0.5 to 0.7 𝜇𝜇L of the DNA
under investigation were used, for a total reaction volume of
20.0 𝜇𝜇L. e reaction buffer contained 50mM KCL, 10mM
Tris-HCL pH 8.4, 2.5mMMgCL2, 2.0 pmol of each “primer,”
200 𝜇𝜇M of each deoxynucleotide triphosphate (dATP, dCTP,
dGTP, and dTTP), 2.5 units of Taq polymerase (Gibco-BRL),
and sufficient water to give the total volume of 20.0 𝜇𝜇L. e
reaction mixture was covered with 100 𝜇𝜇L of mineral oil and
the tubes were placed in a DNA ermal Cycler (Perkin-
Elmer).
e reactions that followed were found to be optimal.
e samples were heated to 94∘C for 60 s to denature the
DNA, cooled to 57∘C for 90 s to allow the primers and the
DNA to reanneal, and then heated to 72∘C for 120 s for
primer extension. By the �nal cycle, the extension period was
7min. A total of 40 cycles were performed. e ampli�ed
product was detected by direct gel analysis. 5𝜇𝜇L of the
reaction mixture were subjected to electrophoresis with 2%
agarose minigel, and the DNA was visualized using UV
�uorescence aer stainingwith ethidiumbromide.Molecular
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(a)
(b)
F 1: Automated sequencing (Abi Prism 377) for the ureC region ofH. pylori. Positive samples forH. pylori infection obtained from PCR
in order to prove that the sequences being ampli�ed did belong to the genetic sequence of a DNA segment of the urease-C area of H. pylori
(enzymes HhaI andMboI). All DNA samples taken from the patients presented genetic sequences similar to the one ofH. pylori, as described
for the urease-C area of the Gene Bank (I Square 1).
weight markers were included in each gel. An 820 base-pair
band was seen when samples were ampli�ed using primers
P1 and P2 to detect H. pylori (Table 1 and Figure 1).
2.2.4. PCR-Based Restriction Fragment Length Polymorphism
Typing of Helicobacter pylori (RFLP). A�er the ampli�cation
was con�rmed, the PCR product was submitted to digestion
with the restriction enzymes HhaI and MboI for fragmenta-
tion of Urease-C [16].
e fragments which were produced were submitted to
electrophoresis in a 2% gel agarose 1000 (Gibco-BRL), stained
with ethidium bromide, visualized under ultraviolet light
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M 241 300 260 260 300 270
181 296 240 240 296 267
158 114 230 230 114 178
140 110 90 90 110 105
M 1(H2) 2(H3) 3(H3) 4(H2) 5(H4)C+(H1)
C−
C−
F 2: Digestion patterns with the enzyme HhaI found in some
analyzed samples. Electrophoresis in 2% agarose gel 1000, stained
with bromide ethidium. M marker of molecular weight, C+ (1),
1(H2), 2(H3), 3(H4), 4(H4), 5(H2), C-negative control. Note: the
most frequent pattern found was H4, with 14 patients (25.8%).
M 320 308 280 308 300 480
300 275 230 275 220 300
200 237 120 237 200 40
100
90
100
M 1(M2) 2(M4) 3(M2) 4(M5) 5(M3)C+(M1)
C−
F 3: Digestion patterns with the enzymeMboI found in some
analyzed samples. Electrophoresis in 2% agarose gel 1000, stained
with ethidium bromide. M marker of molecular weight; C+(M1);
1(M2); 2(M4); 3(M2); 4(M5); 5(M3); C-negative control. Note 1:
Pattern M4 was the most frequent, with 15 patients (25.8%). Note
2: patient 1(M2) presented very clear bands in this analysis, but in a
posterior analysis it was possible to classify this patient in groupM2.
and photographed in Polaroid System. e patterns which
were found were compared and analyzed with the com-
putational program Bio 1D (Analysis of Restriction—PCR-
RFLP—Restriction Fragment Length Polymorphism), ver-
sion 99 (Vilber Loumart) (Figures 2 and 3).
T 2: Comparison between PCR and urease test in fresh biopsy
samples.
Urease test PCR
Positive 64 64
Negative 18 18
Total 82 82
100% agreement.
T 3: Comparison between PCR and histology test in paraffin
biopsy samples.
Histology PCR
Positive 59 12
Negative 0 47
Total 59 59
Positive Beta Globin (DNA detection) — 14
Negative Beta Globin (no DNA detection) — 45
Total 0 59
∗
Two paraffin samples were positive for the Beta Globin gene, but negative
for the H. pylori gene.
Approximately 10 𝜇𝜇L of the ampli�ed product were used
for the digestion process which also contained 2.0𝜇𝜇L of the
corresponding enzyme. �ater was added to �ll 20.0𝜇𝜇L and
the mixture was placed in a 37∘C bath overnight.
2.2.5. Automatic Sequencing. Automatic sequencing was per-
formed using the program Abi Prism, model 377, version
3.4, and Abi 100, version 3.2. Sequencing allowed for the
identi�cation of the studied DNA region (Primers P1 and
P2). Figure 1 shows the automatic sequencing, proving that
the sequence is Helicobacter pylori.
3. Results
A total of 141 endoscopic biopsy samples from 131 patients
were studied forH. pylori infections with PCR and the results
were compared with Urease and Histology tests. 82/64 (78%)
fresh samples had a positive Urease test for H. pylori. A PCR
test detected all of the 64 positive samples identi�ed by the
Urease test (100%) (Table 2).
Fiy-nine paraffin biopsies, all found to be positive
through a histological examination, were submitted to the
DNA extraction procedure and Beta-Globin PCR to prove
the quality and the presence of DNA in the extracted samples.
Only 14/59 (23.7%) samples were positive for the Beta Globin
gene, but in two of themH. pylori was not ampli�ed by PCR,
even though they had a positive Histology test (Table 3). In
the other 45 samples, it was impossible to detect Beta Globin
in the DNA using PCR, primarily because of the low amount
of paraffin samples and/or because the reaction was inhibited
due to paraffin and xilol in the extraction procedures.No con-
tamination occurred and the samples were tested two times.
Among the 141 fresh endoscopic biopsy samples, 58 were
tested using the RFLP technique to detect the different H.
pylori strainswith the restriction enzymes HhaI and MboI.
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T 4: Use of the Restriction Fragment Length Products (RFLP) technique for genotyping the positive H. pylori PCR products using
restriction enzymes (HhaI andMboI).
Restriction enzyme Frequency (%) Disease Median age (years)
HhaI-1 1/58 ( 1.7) Gastritis + ulcers 41
HhaI-2 5/58 (8.6) 3 Gastritis; 2 ulcers 29
HhaI-3 12/58 (20.7) 9 Gastritis; 3 ulcers; 45
HhaI-4 14/58 (24.1) 8 Gastritis; 3 ulcers; 1 esophagitis; 1 I��a�atio� 39
HhaI-5 3/58 (5.2) 1 Gastritis; 2 ulcers 54
HhaI-6 6/58 (10.3) 3 Gastritis; 2 ulcers; 1 Gastritis + ulcers 39
HhaI-7 1/58 (1.7) 1 ulcers 19
HhaI-8 4/58 (6.9) 1 Gastritis; 2 ulcers; 1 esophagitis 48
HhaI-9 2/58 (3.4) 1 Gastritis; 1 ulcers 37
HhaI-10 2/58 (3.4) 2 ulcers 72
HhaI-11 8/58 (13.8) 6 Gastritis; 1 in�amation; 1 ulcers 54
MboI-1 2/58 (3.4) 2 Gastritis 72
MboI-2 13/58 (22.4) 7 Gastritis; 5 ulcers, 1 esophagitis 39
MboI-3 8/58 (13.8) 3 Gastritis; 3 ulcers; 1 in�amation 49
MboI-4 15/58 (25.8) 10 Gastritis; 5 ulcers 57
MboI-5 4/58 (6.9) 1 Gastritis; 1 ulcers; 1 esophagitis; 1 Gastritis ulcers 27
MboI-6 2/58 (3.4) 1 Gastritis; 1 ulcers 37
MboI-7 4/58 (6.9) 1 Gastritis, 1 splenomegaly; 2 ulcers 50
MboI-8 1/58 (1.7) 1 Gastritis 45
MboI-9 5/58 (8.6) 2 Gastritis; 2 ulcers; 1 Gastritis + ulcers 47
MboI-10 2/58 (3.4) 2 Gastritis 28
MboI-11 1/58 (1.7) 1 Gastritis 31
MboI-12 1/58 (1.7) 1 Gastritis 38
All 58 samples showed positive PCR for Beta Globin and
H. pylori genes. e product obtained from the H. pylori
ampli�cation gene by direct PCR was 820 base pairs. �leven
digestion patterns for HhaI and twelve for MboI were found
(Table 4). e most frequent patterns were HhaI–3 with
12.58 (18.3%), HhaI-4 with 14.58 (23.3%),MboI-2 with 13.58
(21.7%), and MboI-4, with 15.58 (23.3%). e median age
was 45, 39, 39, and 57, respectively, in each of the detected
patterns. e most frequent diseases in the patients of this
study were Gastritis and ulcers.
4. Discussion
Gastric cancer is one of neoplasms that cause the majority of
deaths not only in Brazil but all over the world. e type of
cancer caused byH. pylori could be linked to gastric chronic.
Differences in the degree of virulence between strains have
lead to an increased risk of developing gastric diseases [17].
e H. pylori infection is distributed in a cosmopolitan
way, reaching mainly the adult population of low socioeco-
nomic levels in developing countries.e discharge infection
rate is correlated with bacterial virulence and inherent factors
of the particular host, mainly with respect to the immune
system [18].
It should be noticed that the route of fecal-oral transmis-
sion appears to be the biggest problem in the prevalence of
infection, making H. pylori a serious public health problem
in both developed and developing countries [19].
e present study analyzes the effectiveness of the molec-
ular biology method PCR in the detection of H. pylori in
patients with gastrointestinal symptoms, comparing it with
the histology and rapid urease test.
e polymerase chain reaction (PCR) for the diagnosis
of H. pylori is a very sensitive and speci�c method [20], pro-
viding fast and safe diagnosis. Many results indicate that PCR
sensitivity is close to that of culture tests [21], but for verifying
the eradication of H. pylori the effectiveness of PCR can be
markedly superior [22, 23]. e methodology used in other
studies to distinguish the differentH. pylori subtypes has been
PCR-RFLP [24] that through analyzis of the PCR product
with restriction endonucleases that resulting fragments of dif-
ferent sizes and the digestion pro�le is decisive to de�ne the
strains. e restriction enzymes HhaI and MboI were used
for the Urease-C area [16]. e extreme degree of variability
observed among the strains ofH. pylori became an important
focus of scienti�c attention, as the investigators recognized
the signi�cant impact that this phenomenon can have on
several research areas, such as the development of vaccines,
the development of resistance to antimicrobial agents, and the
study of the pathogen-host interaction [25, 26]. Considering
that 10 to 20% of people infected with H. pylori develop
obvious diseases, the reliable identi�cation of the lineages
could actually be very bene�cial [27]. Previous studies that
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have used several techniques characterized H. pylori as a
highly variable species that presents countless lineages, each
one with its own and different genotype [28–31].
e genotyping of H. pylori is important for character-
izing the most pathogenic genotype and the most frequent
strain.is information can be used for clinical and epidemic
studies. Even if many infections are clinically silent, the
organism infected with H. pylori presents increased morbid-
ity and mortality [5, 32, 33].
In the present study we standardized PCR with material
obtained from the fresh endoscopic biopsies samples of
patients attending Gastrocentro (the Center of Digestive
Tract Studies), Medical School, UNICAMP. Some of the
gastric biopsy samples were collected in paraffin and some
were not. With regard to the standardization of the DNA
extraction technique from the paraffin biopsy samples, sev-
eral difficulties were found, because the samples contained a
small amount of tissue fragments and many of the paraffin
samples did not amplify the 𝛽𝛽-Globin gene, demonstrating
degraded DNA of poor or inhibited quality.
PCR was used because it is more speci�c and faster
when compared to other methods; the product of PCR can
be processed with restriction enzymes to verify H. Pylori
strains. Besides, starting with the PCR, DNA sequencing can
be made to verify mutations, which no other technique is
capable of doing.
As an internal control of the reaction was used in all
samples (human 𝛽𝛽-Globin gene), in the fresh-air biopsy
samples positive for H. pylori, we had 100% PCR ampli�ca-
tion. However, in several paraffin samples, the 𝛽𝛽-Globin did
not amplify, indicating an inefficient DNA extraction of the
samples.
e efficiency ofH. pylori detection PCR in fresh samples
was superior to that in the paraffin samples. We suspect that
PCR inhibitionmay have occurred due to themethod used in
DNAextraction fromparaffin or the fact that that the samples
were insufficient.
e extraction of DNA from fresh samples had excellent
results. Among the 82 analyzed samples, 64 were positive and
18 negative, with 100% in agreement with PCR.
In the present study, we used the PCR-RFLP method
for the differentiation of H. pylori strains from specimens
obtained from gastric biopsies taken from Brazilian patients.
Using this methodology we observed that 12 and 11 patterns
were produced, respectively, by the two restriction enzymes
MboI and HhaI from 58 specimens obtained from gastric
biopsies. Twowere samples of biopsies in paraffin and 58were
samples of nonfastened gastric biopsies (Table 1).
is data suggests that genotyping using PCR-RFLP can
be useful as a fast procedure for the speci�c identi�cation
of H. pylori lineages in gastric biopsies specimens [16].
Several protocols of genotyping analysis were proposed for
distinguishing the lineages of clinically isolated H. pylori
[34–38]. Several primer pairs were described for detection
and the typing of H. pylori was based on the ampli�cation
of the ureA [34], ureA plus ureB [35], and ureC genes
[36, 38]. ese results demonstrate great diversity in the
urease genes in clinical H. pylori samples. Li et al. [16]
found 3, 11, and 6 different patterns which were produced
by 19 clinically isolated samples, respectively, digested by
the restriction enzymes HhaI, MboI and AluI. Foxall et al.
[35] found 10 different patterns which were produced by
22 clinically isolated samples, when the restriction enzyme
HaeIII digested the PCR product of 2.4 Kb which had been
ampli�ed by the ureA and ureB genes. Lopez et al. [37] found
that the patterns generated by the digestion of PCR products
with the HaeIII enzyme, starting from ureA and ureB, were
almost as different as the standard HaeIII. Akopyanz et al.
[28] found 18 MboI and 27 HaeIII RFLP patterns, PCR
products ampli�ed by ureA and ureB genes of 2.4 Kb of 60
H. pylori lineages, and that the patterns distinguished 44
separate groups. Each isolated group did not differ from the
other ones in the RFLP analyses of ureA and ureB products,
but differed in MboI digestion of the 1.7 Kb ureC and ureD
segments. Such a fact indicates that PCR-RFLP analyses of
ureC genes can produce a great number of standard RFLPs.
Several studies have con�rmed that PCR-RFLP analysis
of the ureC gene can differentiate clinically isolatedH. pylori.
Using restriction endonucleases, Moore et al. [38] analyzed
the 1.1 Kb portion of the ureC gene ampli�ed by the �PCR�
of 21 clinically isolated H. pylori. e samples were divided
into four groups aer digestion with the enzyme HindIII,
while the lineages were divided into 15 groups aer they were
digested with the enzymesAluI and PvuI. Fujimoto et al. [36]
demonstrated that the digestion of 820 bp of the H. pylori
ureC gene with the restriction enzymes HhaI, MboI, and
MseI resulted in 10, 10, and 11 different patterns, respectively.
Dooley et al. [3] used three types of enzymes in the PCR
product of a 1.179 bp portion of the H. pylori ureC gene.
Eleven, 10, and 6 digestion patterns were produced by the
HhaI, MboI, and AluI enzymes, respectively.
In our study we used two types of restriction enzymes in
the ampli�ed products of 820 pb of the H. pylori ureC gene.
We obtained 11 and 12 different patterns, respectively, from
the 58 clinically isolated samples which were studied. Our
results suggest that the PCR-RFLP analysis of this portion
of the H. pylori ureC gene is a reliable method, and that
genotyping of PCR in this area can be used for epidemic
studies and for the differentiation of isolatedH. pylori strands.
is study also revealed a high level of genetic diversity
isolated in the different H. pylori positive patients studied in
Brazil.
e obtained genotyping patterns were compared using
the computational program Bio 1D. We found 11 patterns
with theHhaI enzyme and 12 patternswith theMboI enzyme.
e reason for the small number of studied samples was due
to the fact that it was not possible to establish a signi�cant
statistical correlation between speci�c digestive pathologies
and standard genotypes.
We believe that the genotyping ofH. pylori can contribute
to the study of the microorganism’s characteristics, facili-
tating the detection of pathogenic or nonpathogenic strains
and, in turn, providing a better understanding of the several
virulence factors that the bacterium uses to cause diseases.
4.1. Statistics. Percentage agreement was calculated to com-
pare H. pylori genotypes obtained from PCR performed
directly on gastric biopsies, with the genotypes obtained from
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the PCR of DNA extracted from paraffin and fresh samples,
as well as histology and urease tests.
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